2023 Annual Report of Ageing and Neurodegenerative Diseases (AND)
In the ever-evolving landscape of neuroscience, Ageing and Neurodegenerative Diseases (AND) remains committed to advancing knowledge at the intersection of ageing and neurodegenerative diseases. The 2023 Annual Report serves as a testament to the dedication of our esteemed contributors, the resilience of our Editorial Board, and the unwavering support of our reviewers and readership. Reflecting on the past year, we are filled with gratitude for the collective efforts that have shaped AND into a thriving hub of cutting-edge research and collaboration. The Editorial Office will outline the Key Highlights of 2023 in the following six sections.
In 2023, AND received a total of 58 submissions and successfully published 24 articles across four issues, as illustrated in Figure 1. These contributions covered a diverse range of topics, including Alzheimer's disease, Parkinson's disease, Rett syndrome, amyotrophic lateral sclerosis, stroke, ageing, and Essential tremor, among others. As shown in Figure 2, the H-index of most corresponding authors falls within the range of 10-30. It is noteworthy that 9% of corresponding authors have an H-index exceeding 100. The reviewers for these articles come from 14 countries worldwide, with the majority from China and the United States [Figure 3]. Their constructive comments substantially raised the value of the publications, accelerating the development of AND. The AND Editorial Office appreciates these reviewers for their valuable contribution of time and effort.
Figure 1. Issue Covers Published in 2023
Figure 2. Distribution of H-Index of Corresponding Authors for Articles Published in 2023
Figure 3. Distribution of reviewers by country/region
In 2023, Ageing and Neurodegenerative Diseases (AND) achieved significant milestones by being successfully indexed in J-Gate and CAS databases. Furthermore, a submission for inclusion in Scopus was made at the end of October, 2023 and is currently undergoing the final round of evaluation. This endeavor is poised to further enhance AND's standing on the international academic stage, underscoring our commitment to maintaining a high standard of academic excellence.
Since its inception in 2021, AND's inclusion in multiple databases within a short span marks a notable achievement. This not only propels advancements and innovation in the field of ageing and neurodegenerative diseases but also solidifies AND's aspiration to grow into a premier journal in the domain.
Figure 4. The databases that officially included AND in 2023
In 2023, the number of citations for AND exceeded 50 times (based on data searchable in Web of Science). As shown in Figure 5, 64% of the citations originated from journals in the Q1 category, while 25% came from Q2 category journals. Additionally, Table 1 provides detailed information on journals with an Impact Factor (IF) exceeding 10 that cited AND articles, along with the citation frequency for each journal. These data not only validate AND's academic achievements in 2023 but also indicate its potential for development and future impact in the field of Neuroscience.
Figure 5. Distribution of citations by countries/regions of citations
Table 1. Citing Journals of AND in 2023 (IF>10)
Figure 6. Quartile distribution of citing journals
Editorial Board and Youth Editorial Board Members
In 2023, the Editorial Board of Ageing and Neurodegenerative Diseases (AND) stabilized, welcoming two distinguished Editorial Board members and three Youth Editorial Board members. As illustrated above [Figure 7], the new Editorial Board members include Jeremy Van Raamsdonk from Canada and Francesco Marotta from Italy. The Youth Editorial Board members consist of Sofie Hindkjær Lautrup from Norway, Hongjun Fu from the United States, and Yongchang Chen from China. Each of them specializes in different aspects of ageing and neurodegenerative diseases, injecting fresh perspectives and expertise into the AND journal.
Figure 7. New members who joined the Editorial Board & Youth Editorial Board in 2023
Looking ahead to 2024, AND aims to further expand its Editorial Board, actively seeking diverse professional knowledge and recruiting outstanding scholars and experts within the journal's scope. This commitment reflects AND's dedication to fostering broader academic exchanges and collaborations.
As depicted in Figure 8, AND successfully collaborated with 26 distinguished scholars to organize 18 Special Issues in 2023. These issues cover a wide range of hot topics within the journal's scope, including Sleep Disorders, Gut-Brain Axis, Cerebellum, Cognitive Functions, Autophagy, and more.
Figure 8. Covers of Special Issues launched in 2023
The Editorial Office extends its gratitude to the esteemed scholars for their valuable contributions, enriching the journal with diverse perspectives and advancing the discourse in these crucial areas.
Weekly News & Online Webinars
As a distinctive feature of AND, the Weekly News column thrived in 2023, presenting a total of 49 issues [Figure 9]. Curating content from over 40 topics, it highlighted 245 newly published articles. As of January 15, the cumulative views surpassed 11,043. This column serves as a conduit to communicate the latest research findings within the scope of the journal, fostering a close-knit channel of interaction between authors and readers.
Figure 9. Covers of Weekly News launched in 2023
AND successfully organized/co-organized 5 online webinars in 2023, drawing an audience of over 400,000+ participants from various broadcasting platforms. These webinars garnered significant attention from the academic community. The Editorial Office expresses profound gratitude to all the experts and scholars for their support in these webinars [Figure 10]. Thanks for their continued support, which has been instrumental in the success of these events
Figure 10. Detailed information about the Online Webinars in 2023
As we embark on this journey through the pages of our 2024, we invite you to join us in celebrating the achievements and advancements in 2023 that have shaped AND into a dynamic platform for intellectual exchange and scholarly excellence.
Thank you for your continued support, and we look forward to another year of collaborative exploration and discovery.
Editors: Yuan Gao, Sixuan Zhang, Yiying Song, Siqing Hu
Language Editor: Catherine Yang
Production Editor: Yan Zhang
Respectfully Submitted by the Editorial Office of Ageing and Neurodegenerative Diseases